The impact of dupilumab treatment on severe acute respiratory syndrome coronavirus 2-coronavirus disease 2019 antibody responses in patients with atopic dermatitis
Benjamin Ungar, Leore Lavin, Alexandra Golant, Alyssa Gontzes, Eden David, Yeriel Estrada, Giselle Singer, Ana B. Pavel, Emma Guttman‐Yassky
Topics & Concepts
DupilumabAtopic dermatitisCoronavirusCoronavirus disease 2019 (COVID-19)MedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakDiseaseRespiratory systemBetacoronavirusImmunologyDermatologyVirologyInfectious disease (medical specialty)Internal medicineOutbreakDermatology and Skin DiseasesUrticaria and Related ConditionsAllergic Rhinitis and Sensitization